|Articles|May 1, 2001
- Pharmaceutical Executive-05-01-2001
- Volume 0
- Issue 0
Policy: Task Masters
Author(s)Kevin Gopal
London-Government and industry have agreed there should be no weakening of patent protection in the effort to speed access to medicines in the developing world.
Advertisement
Articles in this issue
about 25 years ago
Pharmacia's Carrie Cox: HBA Woman of the Yearabout 25 years ago
Friends of Complexityabout 25 years ago
Under Federal Fireabout 25 years ago
Task Force: Enter the Fixersabout 25 years ago
The Next Y2Kabout 25 years ago
Political ScienceAdvertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
How Exposed is The U.S. Pharmaceutical Supply Chain to China’s Updated Export Control Regulations?
2
Bristol Myers Squibb Expands Collaboration with Nvidia to Build AI Factory
3
Pharmaceutical Executive Daily: Bristol Myers Squibb Expands Partnership with Nvidia
4
Staying Ahead of Viral Evolution: Q&A with Robert Allen, Ph.D
5